Ricciardi Lisa 4

What Happened

• Lisa Ricciardi, CEO, President and Director of Cognition Therapeutics (CGTX), had 5,850 shares withheld by the company to cover tax withholding related to the vesting of restricted stock units. The withholding was recorded as a disposition at $1.12 per share, totaling $6,552. This was not an open-market sale but an internal tax-withholding action.

Key Details

• Transaction date: 2026-02-15; Form 4 filed: 2026-02-18.
• Amount withheld/disposed: 5,850 shares at $1.12 each; total value $6,552.
• Shares owned after transaction: not specified in the provided filing.
• Footnote: F1 — issuer withheld these shares to cover tax withholding obligations tied to RSU vesting.
• Filing timeliness: no late-filing flag indicated in the provided data.

Context

• This is a routine tax-withholding event following RSU vesting (common for executives) and differs from an open-market sale — it generally should not be interpreted as a bearish insider trade. The cash value involved is small relative to typical executive transactions.